| Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Juvenile Myelomonocytic Leukemia
|
26 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.820 | 1.000 | 2 | 2005 | 2019 | |||||
Colorectal Carcinoma
|
1186 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.923 | 13 | 1999 | 2020 | |||||
Carcinoma of lung
|
995 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.800 | 0.933 | 12 | 2010 | 2019 | |||||
Non-Small Cell Lung Carcinoma
|
601 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.790 | 1.000 | 9 | 2002 | 2019 | |||||
Pancreatic carcinoma
|
236 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.740 | 1.000 | 4 | 2003 | 2019 | |||||
Organoid Nevus Phakomatosis
|
5 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.730 | 1.000 | 3 | 2012 | 2019 | |||||
Arteriovenous Malformations, Cerebral
|
3 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 1 | 2019 | 2019 | |||||
Leukemia, Myelocytic, Acute
|
247 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 1 | 1987 | 2014 | |||||
NEVUS, EPIDERMAL (disorder)
|
4 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 1 | 2010 | 2010 | |||||
ovarian neoplasm
|
229 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 1 | 2005 | 2011 | |||||
Stomach Carcinoma
|
616 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 1 | 1987 | 2004 | |||||
Stomach Neoplasms
|
9 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.710 | 1.000 | 1 | 2015 | 2015 | |||||
Neoplasms
|
1571 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.970 | 67 | 1999 | 2020 | |||||
Carcinogenesis
|
355 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.857 | 14 | 2003 | 2016 | |||||
Adenocarcinoma of lung (disorder)
|
183 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 13 | 2008 | 2019 | |||||
Malignant neoplasm of lung
|
1000 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 11 | 2009 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 11 | 2010 | 2019 | |||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
62 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2010 | 2018 | |||||
Malignant Neoplasms
|
1441 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 10 | 2009 | 2019 | |||||
Lung Neoplasms
|
39 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.080 | 0.875 | 8 | 2008 | 2016 | |||||
Adenocarcinoma
|
167 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.070 | 1.000 | 7 | 2012 | 2020 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2012 | 2019 | |||||
Neoplasm Metastasis
|
327 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2009 | 2016 | |||||
Malignant neoplasm of pancreas
|
238 | 0.492 | 0.680 | 12 | 25245350 | missense variant | C/A;G;T | snv | 4.0E-06 | 0.050 | 1.000 | 5 | 2003 | 2019 |